The clinical relevance of urine-based markers for diagnosis of bladder cancer

By Eissa Sanaa  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 513-518

Humana Press, Inc

Access to resources Recommend Favorite

The use of the marker tumor concept in Ta, T1 bladder cancer - Is it justified?

By van der Meijden A.P.M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 1, 2002-01 ,pp. : 31-33

Elsevier

Access to resources Recommend Favorite

Ethical and Design Issues of Phase I Clinical Trials in Cancer Patients

By Grunwald Hans W.  

Cancer Investigation, Vol. 25, Iss. 2, 2007-03 ,pp. : 124-126

Informa Healthcare

Access to resources Recommend Favorite

Role of Tumor Suppressor and Angiogenesis Markers in Prediction of Recurrence of Non Muscle Invasive Bladder Cancer

By Agrawal Usha  

Pathology & Oncology Research, Vol. 17, Iss. 1, 2011-03 ,pp. : 91-101

Springer Publishing Company

Access to resources Recommend Favorite

Circulating molecular markers in pancreatic cancer: ready for clinical use?

By Gall Tamara MH   Frampton Adam E   Krell Jonathan   Castellano Leandro   Jiao Long R  

Future Oncology, Vol. 9, Iss. 2, 2013-02 ,pp. : 141-144

Future Medicine

Access to resources Recommend Favorite